MarketInOut Stock Screener Log In | Sign Up

GRAIL Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
GRAIL Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7,053.69 mln
Float42.16 mln
Earnings Date11/04/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.19
Caution advised

1-Year Forecast

132.56
Limited downside

Relative Strength

97 / 100
Top performer

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-320%
Severely loss-making

Business Description

GRAIL Inc. is a U.S.-based healthcare company focused on detecting multiple types of cancer at early stages through blood-based testing. Its flagship product, Galleri, screens for cancer in people over 50 who show no symptoms, while a separate test helps doctors reach faster conclusions for patients already suspected of having cancer. Founded in 2015 and based in Menlo Park, California, GRAIL also supports clinical research and offers tools that help track how cancer responds to treatment over time.

Key Fundamentals

EPS-9.70
ROE-16.08
RPS4.11
ROIC-19.06
ROA-13.86
EBITDA, mln-374
EV / EBITDA-15.64
EV / EBIT-11.05
Revenue, mln165
EV / Revenue35.40

Quote Details

Last 143.43
Change -15.49 (-9.75%)
Open 152.08
Volume 1,072,294
Turnover 153,799,120
Average Volume 968,266

Financial Ratios

Pre-Tax Profit Margin-320
Leverage Ratio1.12
Current Ratio10.95
Price / Book2.65
Price / Tangible Book8.84
Debt / Equity0.04
Price / Sales36.64

Financial Strength

Altman Z-Score7.12
Piotroski F-Score 4 / 9
Beneish M-Score-2.19
1-Year Target Price132.56
Short Ratio5.44
Short % of Float18.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.21% 92 / 100   
1 Month 8.2% 89 / 100   
2 Months 111% 99 / 100   
6 Months 163% 99 / 100   
1 Year 66.08% 94 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog